Rheumatic fever: A never-ending story?

Israel Medical Association Journal

Volumn 2, Issue 6, 2000, Pages 480-481

  Harel, Liora ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune response; Carditis; M protein; Rheumatic fever; Streptococcus

Indexed keywords

ALLOANTIGEN; ANTIBIOTIC AGENT; B LYMPHOCYTE ANTIGEN;

AUTOIMMUNITY; CARDITIS; DEVELOPING COUNTRY; EDITORIAL; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; ISRAEL; MEDICAL RESEARCH; NONHUMAN; PROTEIN ANALYSIS; RHEUMATIC FEVER; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

HUMANS; MYOCARDITIS; RHEUMATIC FEVER;

EID: 0033843784     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. The virtual disappearance of rheumatic fever in the United States: Lessons in the rise and fall of the disease
2. Rheumatic fever in the 1980s
3. Rheumatic fever. The relationships between host, microbe and genetics
4. Centers for Disease Control: Acute rheumatic fever - Utah
5. Rheumatic fever
6. Harvean lectures on the various manifestations of the rheumatic state as exemplified in childhood and early life
7. Association of a B cell alloantigen with susceptibility to rheumatic fever
8. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody
9. Association of class II human histocompatibility leucocyte antigens with rheumatic fever
10. HLA A, B DR and DQ antigens in black patients with severe chronic rheumatic heart disease
11. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population
12. Rheumatic fever in the Nazareth area during the last decade
13. Review of 222 cases of acute rheumatic fever in Southern Israel
14. Rheumatic fever and rheumatic heart disease: A twenty year report on 1,000 patients followed since childhood
15. Resurgence of acute rheumatic fever in the intermountain area of the United States
16. The changing face of rheumatic fever in the 20th century
17. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments